|
17/01/2025
|
18:25
|
Replacement - Form 8.3 - Poolbeg Pharma plc
|
RNS
|
|
17/01/2025
|
11:27
|
Form 8.3 - Poolbeg Pharma plc
|
RNS
|
|
17/01/2025
|
10:07
|
Form 8.5 Poolbeg Pharma PLC
|
RNS
|
|
16/01/2025
|
13:53
|
Form 8.3 - Poolbeg Pharma plc
|
RNS
|
|
16/01/2025
|
09:29
|
Form 8.5 (EPT/NON-RI)
|
RNS
|
|
15/01/2025
|
18:04
|
Form 8.3 - Poolbeg Pharma plc
|
RNS
|
|
15/01/2025
|
14:57
|
Form 8.3 - HOOKIPA PHARMA INC
|
RNS
|
|
15/01/2025
|
14:30
|
Form 8.3 - HOOKIPA Pharma Inc.
|
Business Wire
|
|
15/01/2025
|
10:31
|
Form 8.5 Poolbeg Pharma PLC
|
RNS
|
|
14/01/2025
|
17:33
|
Form 8.3 - Poolbeg Pharma plc
|
RNS
|
|
14/01/2025
|
17:32
|
Form 8.3 - Poolbeg Pharma plc
|
RNS
|
|
13/01/2025
|
18:28
|
Form 8.3 - Poolbeg Pharma plc
|
RNS
|
|
13/01/2025
|
10:23
|
Form 8.5 (EPT/NON-RI)
|
RNS
|
|
10/01/2025
|
11:48
|
Form 8.5 (EPT/NON-RI)
|
RNS
|
|
10/01/2025
|
10:47
|
Form 8.5 (EPT/NON-RI)
|
RNS
|
|
10/01/2025
|
07:00
|
Update Potential Combination of Poolbeg & HOOKIPA
|
RNS
|
|
09/01/2025
|
16:28
|
Form 8.5- Poolbeg Pharma PLC
|
RNS
|
|
09/01/2025
|
08:53
|
Form 8.5 (EPT/NON-RI)
|
RNS
|
|
09/01/2025
|
07:00
|
Holding(s) in Company
|
RNS
|
|
08/01/2025
|
15:56
|
Form 8.5 (EPT/NON-RI) - Poolbeg Pharma PLC
|
RNS
|
|
08/01/2025
|
15:53
|
Form 8 (OPD) - Poolbeg Pharma plc
|
RNS
|
|
08/01/2025
|
09:44
|
Form 8.5 (EPT/NON-RI)
|
RNS
|
|
07/01/2025
|
10:48
|
Form 8.5 (EPT/NON-RI)
|
RNS
|
|
07/01/2025
|
07:00
|
Update Potential Combination of Poolbeg & HOOKIPA
|
RNS
|
|
06/01/2025
|
10:27
|
Form 8.5 (EPT/NON-RI)
|
RNS
|
|
03/01/2025
|
11:40
|
Form 8.5 (EPT/NON-RI)
|
RNS
|
|
02/01/2025
|
07:00
|
Combination of Poolbeg and HOOKIPA Pharma Inc.
|
RNS
|
|
20/11/2024
|
07:00
|
POLB 001 Patent Granted in United States
|
RNS
|
|
18/09/2024
|
07:00
|
Interim results for the six months to 30 June 2024
|
RNS
|
|
12/08/2024
|
13:28
|
Holding(s) in Company
|
RNS
|
|
26/07/2024
|
07:00
|
Voluntary Delisting from OTCQB Market
|
RNS
|
|
10/07/2024
|
07:00
|
Notification of Major Holdings
|
RNS
|
|
02/07/2024
|
07:00
|
Change of Registered Address
|
RNS
|
|
17/06/2024
|
08:38
|
Result of AGM
|
RNS
|
|
09/05/2024
|
07:00
|
Annual Report & AGM Notice
|
RNS
|
|
01/05/2024
|
07:00
|
Significant POLB 001 Patent Granted in USA
|
RNS
|
|
30/04/2024
|
07:02
|
Appointment of Joint Broker
|
RNS
|
|
30/04/2024
|
07:00
|
Results for the year ended 31 December 2023
|
RNS
|
|
30/04/2024
|
07:01
|
Option Agreement to Acquire Orphan Drug Candidate
|
RNS
|
|
29/04/2024
|
07:00
|
TR-1: Notification of major holdings
|
RNS
|
|
22/02/2024
|
07:00
|
Director/PDMR Shareholding
|
RNS
|
|
19/02/2024
|
13:42
|
Director Share Purchase
|
RNS
|
|
15/02/2024
|
07:00
|
Board Role Change and Launch of EIP
|
RNS
|
|
17/01/2024
|
07:00
|
Further data shows POLB001 potential in cancer CRS
|
RNS
|
|
20/12/2023
|
07:00
|
RSV AI Drug Candidate Analysis Update
|
RNS
|
|
11/12/2023
|
07:00
|
POLB 001 Data Presented at ASH
|
RNS
|
|
30/11/2023
|
07:00
|
Directorate Change
|
RNS
|
|
09/11/2023
|
07:00
|
Former Amryt Pharma Leadership Team join Poolbeg
|
RNS
|
|
03/11/2023
|
07:05
|
POLB001 Data to be Presented at ASH Annual Meeting
|
RNS
|
|
01/11/2023
|
07:00
|
POLB 001 Oncology Programme Update Meeting
|
RNS
|